Literature DB >> 9781806

Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis.

J Thomas1, S Kanangat, B T Rouse.   

Abstract

On infection of the cornea with herpes simplex virus (HSV), an immunopathologic response termed herpetic stromal keratitis (HSK) ensues. This response is mediated primarily by CD4+ T cells and only occurs if mice are infected with replication-competent virus, although replication-defective mutants induce cellular immune responses following infection. To determine the consequences of HSV replication in the cornea, which is crucial for HSK manifestation, corneas infected with productive virus and replication-defective mutants were analyzed for chemokines and proinflammatory cytokine mRNA expression by RT-PCR at various times. While productive infection resulted in rapid upregulation and sustained expression of such chemokines as N51/KC, macrophage inflammatory protein-1beta (MIP-1beta), MIP-2, and monocyte chemotactic protein-1 (MCP-1) and such cytokines as interleukin-1 (IL-1), IL-6, IL-12, and tumor necrosis factor-alpha (TNF-alpha), expression of such inflammatory mediators was minimal and transient after unproductive infection. Expression of MIP-1alpha and lymphotactin along with a biphasic expression of IL-6 and MIP-2 were seen only with productive infection. Initial PMN recruitment into the cornea was approximately 50-fold greater with productive infection than with unproductive infection. These data suggest that a replication-induced proinflammatory milieu in the cornea is crucial for the subsequent progression of HSK possibly because of enhancement of the expression of corneal agonists that drive HSK manifestation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9781806     DOI: 10.1089/jir.1998.18.681

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  25 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice.

Authors:  E Chang; L Galle; D Maggs; D M Estes; W J Mitchell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 3.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

4.  IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.

Authors:  Amol Suryawanshi; Tamara Veiga-Parga; Pradeep B J Reddy; Naveen K Rajasagi; Barry T Rouse
Journal:  J Immunol       Date:  2012-02-29       Impact factor: 5.422

Review 5.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

6.  CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis.

Authors:  Devin M West; Chelsea R Del Rosso; Xiao-Tang Yin; Patrick M Stuart
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

7.  Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.

Authors:  M Zheng; S Deshpande; S Lee; N Ferrara; B T Rouse
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

8.  Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis.

Authors:  Sherrie J Divito; Robert L Hendricks
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Herpes simplex virus type 1 infection associated with atrial myxoma.

Authors:  Yanwen Li; Zhigang Pan; Yuan Ji; Mary Sheppard; Donald J Jeffries; Leonard C Archard; Hongyi Zhang
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

10.  [Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application].

Authors:  M Kernt; C Hirneiss; A S Neubauer; R G Liegl; K H Eibl; A Wolf; H de Kaspar; M W Ulbig; A Kampik
Journal:  Ophthalmologe       Date:  2010-08       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.